Endocrine Today Current Issue

The following articles appeared in the print edition of Endocrine Today.

Table of Contents

• Managing childhood obesity requires commitments from family, community, public policy
• Systematic screening required to detect endocrine complications after childhood cancer
• T Trials shed light on benefits of testosterone therapy
• Diabetes prevention programs for Hispanics Harsimran S. Singh, PhD
• Time management begins with activity management
• Abnormal jugular vein detected during thyroid ultrasound Stephanie L. Lee, MD, PhD, ECNU
• Ambient air pollution exposure tied to diabetes risk in children with overweight, obesity
• Calcium, vitamin D, HT combination improves LDL in postmenopausal women
• CGM without confirmatory blood glucose monitoring safe, effective in type 1 diabetes
• Dapagliflozin lowers all-cause mortality risk in type 2 diabetes
• Deaths from diabetes more common than previously thought
• Endobarrier removal linked to weight gain, worsened glycemic control
• Fear of hypoglycemia ‘psychological stressor’ associated with greater glycemic variability
• Fewer adults with obesity report trying to lose weight
• Incident diabetes risk tied to weight gain in adulthood
• Levothyroxine fails to increase IQ in offspring of women with subclinical thyroid disease
• Liraglutide 3 mg effective for reversing prediabetes
• Major abnormalities on ECG tied to CVD risk in type 1 diabetes
• Oral contraception improves HDL function in overweight, obesity, PCOS
• Previous cancer affects future cancer incidence, mortality risk with pediatric GH therapy
• Prior bisphosphonate use unrelated to atypical femur fractures in osteogenesis imperfecta
• Route of estrogen delivery may affect metabolic parameters in Turner syndrome
• Smaller bone size, less bone turnover in men with hypogonadism type 2 diabetes
• STAMPEDE: Sustained glycemic benefit observed 5 years after gastric bypass in type 2 diabetes, obesity
• Structural disease before pregnancy affects later DTC progression
• Timely medication transitions avoid BMD loss in postmenopausal osteoporosis
• Vagal nerve-blocking therapy safe, effective in type 2 diabetes, obesity
• EBBINGHAUS: Evolocumab does not affect cognitive outcomes
• FOURIER: Reducing LDL to very low levels with evolocumab confers reduced risk for CV events
• HF therapy yields favorable effects on glycemic control
• Will taxing foods with high sugar content make a difference for the obesity epidemic?